| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2142.9 | 2067.5 | 1909.7 |
| Other income | 47.8 | 45.4 | 46.9 |
| Total income | 2190.7 | 2112.9 | 1956.7 |
| Profit before exceptional items & tax | 464.6 | 412.8 | 402.5 |
| Exceptional items | 0.0 | 48.2 | 0.0 |
| Profit before tax | 464.6 | 364.5 | 402.5 |
| Net profit | 342.2 | 300.9 | 319.0 |
| Operating margin | 21.2% | 17.3% | 20.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +7.30% |
|---|---|
| Net profit, quarter on quarter | +13.70% |
| Revenue, year on year | +12.20% |
NSE results filing, NSE: MAXHEALTH. Figures extracted from the filing.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹1,014.00
- Market cap
- ₹98,694 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 67.7×Sector 57.8×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 41.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Annual General Meeting
Max Healthcare Institute Ltd issued a postal ballot notice to seek shareholder approval for its 2026 ESOP scheme, director remuneration, and alterations to its objects clause.
Max Healthcare Institute Other Announcement
Max Healthcare has received an ESG rating of '72' from Niche99, a SEBI-registered provider. This independent rating places the company in the 'Leader' category.
Max Healthcare Institute Legal & Regulatory
Max Healthcare disclosed an update on ongoing NCLT proceedings initiated by BRS Capital against its subsidiary. The next hearing is scheduled for September 28, 2026.
Max Healthcare Institute Employee Stock Options
Max Healthcare Institute Limited has allotted 33,765 equity shares under its ESOP scheme. This increases the total paid-up share capital to 973,310,251 equity shares.
Max Healthcare Institute Employee Stock Options
Max Healthcare allotted 33,765 equity shares under its Employee Stock Option Scheme 2022. The allotment was made at an exercise price of ₹350 per share.
- Value
- ₹1.18 Cr
Max Healthcare Institute Acquisition Worth ₹87.87 Cr
Max Healthcare Institute Limited approved an additional investment of Rs. 87.87 Crore in its subsidiary, Kalinga Hospital Limited. The funds will support capital expenditure and modernization programs.
- Value
- ₹87.87 Cr
- Execution
- Within next 15 days